UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics

Frontiers in microbiology, 2019-05, Vol.10, p.913-913

2019

Volltextzugriff (PDF)

Tolerance and resistance of microbial biofilms

Nature reviews. Microbiology, 2022-10, Vol.20 (10), p.621-635

2022

Volltextzugriff (PDF)

Antibiotic resistance of bacterial biofilms

International journal of antimicrobial agents, 2010-04, Vol.35 (4), p.322-332

2010

Volltextzugriff (PDF)

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

Nature reviews. Microbiology, 2012-12, Vol.10 (12), p.841-851

2012

Volltextzugriff (PDF)

The clinical impact of bacterial biofilms

International journal of oral science, 2011-04, Vol.3 (2), p.55-65

2011

Volltextzugriff (PDF)

In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2683-2690

2012

Volltextzugriff (PDF)

Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4469-4474

2011

Volltextzugriff (PDF)

Evolutionary dynamics of bacteria in a human host environment

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (18), p.7481-7486

2011

Volltextzugriff (PDF)

Sublethal Ciprofloxacin Treatment Leads to Rapid Development of High-Level Ciprofloxacin Resistance during Long-Term Experimental Evolution of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4215-4221

2013

Volltextzugriff (PDF)

Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis

PloS one, 2012-11, Vol.7 (11), p.e50731-e50731

2012

Volltextzugriff (PDF)

Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients

PloS one, 2010-04, Vol.5 (4), p.e10115-e10115

2010

Volltextzugriff (PDF)

High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.196-204

2013

Volltextzugriff (PDF)

Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2276-2282

2005

Volltextzugriff (PDF)

Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients

PloS one, 2018-11, Vol.13 (11), p.e0208013-e0208013

2018

Volltextzugriff (PDF)

Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

Biomedicines, 2022-08, Vol.10 (9), p.2064

2022

Volltextzugriff (PDF)

Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1175-1187

2004

Volltextzugriff (PDF)

Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients

Infection and Immunity, 2007-05, Vol.75 (5), p.2214-2224

2007

Volltextzugriff (PDF)

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum

Frontiers in microbiology, 2014-10, Vol.5, p.554-554

2014

Volltextzugriff (PDF)

The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance

NPJ biofilms and microbiomes, 2020-07, Vol.6 (1), p.28, Article 28

2020

Volltextzugriff (PDF)

Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in Pseudomonas aeruginosa in a Murine Biofilm Wound Model

Frontiers in cellular and infection microbiology, 2021-04, Vol.11, p.652012-652012

2021

Volltextzugriff (PDF)

Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis

Journal of Clinical Microbiology, 2005-10, Vol.43 (10), p.5247-5255

2005

Volltextzugriff (PDF)

Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis

Infection and Immunity, 2005-04, Vol.73 (4), p.2504-2514

2005

Volltextzugriff (PDF)

Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms

Antimicrobial Agents and Chemotherapy, 2004-04, Vol.48 (4), p.1168-1174

2004

Volltextzugriff (PDF)

Antioxidant supplementation for lung disease in cystic fibrosis

Cochrane database of systematic reviews, 2019-10, Vol.10 (10), p.CD007020-CD007020

2019

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Englisch
(111)
Japanisch
(10)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(84)
Pseudomonas Aeruginosa
(72)
Microbiology
(64)
Humans
(54)
Cystic Fibrosis
(47)
Pseudomonas Infections - Microbiology
(36)
Biofilms
(32)
Biological And Medical Sciences
(32)
Pseudomonas Aeruginosa - Genetics
(31)
Pseudomonas Aeruginosa - Drug Effects
(30)
Cystic Fibrosis - Microbiology
(29)
Immunology
(29)
Pharmacology & Pharmacy
(28)
Biofilm
(25)
Infectious Diseases
(25)
Anti-Bacterial Agents - Pharmacology
(24)
Medical Sciences
(23)
Female
(22)
Mutation
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics

Tolerance and resistance of microbial biofilms

Antibiotic resistance of bacterial biofilms

Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective

The clinical impact of bacterial biofilms

In Vivo Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem in Pseudomonas aeruginosa Biofilm Infection

Pharmacokinetics/Pharmacodynamics of Colistin and Imipenem on Mucoid and Nonmucoid Pseudomonas aeruginosa Biofilms

Evolutionary dynamics of bacteria in a human host environment

Sublethal Ciprofloxacin Treatment Leads to Rapid Development of High-Level Ciprofloxacin Resistance during Long-Term Experimental Evolution of Pseudomonas aeruginosa

Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis

Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients

High β-Lactamase Levels Change the Pharmacodynamics of β-Lactam Antibiotics in Pseudomonas aeruginosa Biofilms

Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation

Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes

Adaptation of Pseudomonas aeruginosa to the chronic phenotype by mutations in the algTmucABD operon in isolates from Brazilian cystic fibrosis patients

Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection

Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production

Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum

The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance

Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in Pseudomonas aeruginosa in a Murine Biofilm Wound Model

Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis

Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis

Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms

Antioxidant supplementation for lung disease in cystic fibrosis

Suchergebnisse filtern